Buy 4-FMA Pellets (150 mg) for Advanced Laboratory Research in Europe

4-FMA (4-Fluoromethamphetamine; 1-(4-fluorophenyl)-N-methylpropan-2-amine) represents a critical fluorinated amphetamine-based reference compound for contemporary forensic toxicology, analytical chemistry, and pharmacological investigations across European laboratories. As the definitive EU source for rigorously characterised research chemicals, Pure Lab Chems .eu supplies 4-FMA pellets (150 mg per pellet) exclusively to qualified analytical chemists, biochemists, pharmacologists, and laboratory managers engaged in controlled in vitro research, mass spectral method validation, and monoamine transporter binding studies within institutional frameworks.

Uncompromising Purity and Analytical Characterisation

Every batch of 4-FMA pellets supplied by Pure Lab Chems .eu is guaranteed to achieve a minimum purity of ≥99.0%, as verified by reverse-phase high-performance liquid chromatography (RP-HPLC) with ultraviolet detection at 230 nm and 280 nm. This purity specification is not merely a numerical target; it represents the foundation upon which reproducible, publishable research outcomes depend. Each shipment is accompanied by a comprehensive Certificate of Analysis (CoA) that documents batch-specific HPLC chromatograms, retention time confirmation against certified reference standards, and quantitative impurity profiling with identification of any related amphetamine analogues, fluorinated phenethylamines, or synthetic intermediates.

The CoA further includes residual solvent analysis conducted in accordance with ICH Q3C guidelines, ensuring that levels of dichloromethane, acetonitrile, methanol, and other process-related solvents remain below permitted daily exposure limits. Heavy metal content (lead, cadmium, mercury, arsenic) is verified by inductively coupled plasma mass spectrometry (ICP-MS) and reported at parts-per-million levels, typically below 10 ppm for each element. These stringent specifications distinguish our analytical-grade material from lower-grade industrial reagents that may contain uncharacterised impurities capable of confounding mass spectral interpretations or cellular assay results.

4-FMA pellets (150 mg) are supplied as compressed, uniform tablets exhibiting an off-white to white appearance, consistent with the physical characteristics of fluorinated amphetamine compounds. This physical form is verified through visual inspection under controlled lighting conditions and documented in the CoA with high-resolution imagery. The pellet format ensures precise mass delivery (150 mg ±3 mg per pellet) for stock solution preparation, eliminates the need for manual weighing of fine powders, and facilitates rapid dissolution in appropriate solvents for in vitro applications. For laboratory managers procuring reference standards for LC-MS/MS library development or proficiency testing schemes targeting novel psychoactive substances (NPS), this level of physical and chemical characterisation is non-negotiable.

Principal Laboratory Applications and Research Methodologies

Analytical Toxicology & Forensic Chemistry: 4-FMA serves as a certified reference material (CRM) for mass spectral library development in LC-MS/MS and GC-MS platforms used by forensic toxicology laboratories across the EU. As a fluorinated analogue of methamphetamine, 4-FMA has emerged as a relevant compound in drug-facilitated sexual assault (DFSA) investigations, driving under the influence of drugs (DUID) cases, and post-mortem toxicology screenings. The compound’s characteristic fragmentation pattern under electrospray ionisation (ESI) and electron impact (EI) conditions enables unambiguous identification in complex biological matrices during method validation for toxicological screenings. The presence of the fluorine atom provides a distinctive isotopic signature that facilitates detection in high-resolution mass spectrometry (HRMS) workflows. Laboratories participating in proficiency testing schemes utilise 4-FMA reference standards (150 mg pellets) to calibrate instrumentation, verify extraction recovery rates, and establish limits of detection (LOD) and quantification (LOQ) for novel fluorinated amphetamine analogues.

Chemical Synthesis & Reaction Monitoring: As a high-purity fluorinated amphetamine building block, 4-FMA functions as a reference standard for monitoring synthetic transformations in medicinal chemistry research programmes focused on novel monoamine transporter ligands and psychostimulant analogues. The compound’s well-defined IUPAC structure (1-(4-fluorophenyl)-N-methylpropan-2-amine) provides a stable benchmark against which reaction intermediates and analogues are compared via NMR spectroscopy (particularly ¹⁹F NMR) and HPLC retention time matching. Synthetic chemists developing novel monoamine transporter ligands rely on 4-FMA’s consistent chromatographic behaviour to validate new purification protocols and establish structure-activity relationships (SAR) within the amphetamine class, particularly in relation to structurally similar compounds such as methamphetamine, 2-FMA, 3-FMA, 4-FA, 2-FEA, 3-FEA, and 4-FEA.

Pharmacological In Vitro Assays: Within controlled laboratory environments, 4-FMA is employed in receptor-binding and functional assays using recombinant monoamine transporters (DAT, NET, SERT) expressed in mammalian cell lines. The compound serves as a reference standard in competitive binding assays, enabling determination of Ki and IC₅₀ values for novel monoamine transporter inhibitors and substrates. 4-FMA acts primarily as a dopamine and norepinephrine reuptake inhibitor with moderate affinity for the serotonin transporter, making it a valuable tool for neurochemical and SAR studies. The para-fluoro substitution modulates lipophilicity and metabolic stability relative to unsubstituted methamphetamine, providing critical insights into the pharmacokinetic properties of fluorinated amphetamine analogues. Cellular uptake assays utilise 4-FMA to investigate transporter-mediated flux across blood-brain barrier models, while metabolic stability profiling in primary hepatocyte cultures or liver microsomes establishes intrinsic clearance rates for structure-activity relationship (SAR) investigations. All such applications are strictly limited to in vitro modelling and must be conducted by qualified personnel within appropriate institutional frameworks (university, CRO, or pharmaceutical R&D).

Quality Control & Method Validation: Pharmaceutical quality control laboratories utilise 4-FMA reference standards (150 mg pellets) to validate analytical methods for detecting amphetamine impurities and novel psychoactive substances in drug substance and drug product matrices. The compound’s well-characterised UV absorption spectrum (λmax approximately 230 nm and 280 nm) enables spectrophotometric quantification during assay development, while its stability under accelerated conditions (40°C/75% RH) supports forced degradation studies for regulatory submissions. 4-FMA is particularly valuable for validating methods targeting emerging fluorinated amphetamine analogues in seized materials and biological samples, including differentiation from closely related structural analogues.

Pellet Format Advantages and Handling Protocols

The 150 mg pellet format offers distinct advantages over traditional powder formulations for laboratory reference standards. Each pellet contains a precisely measured 150 mg of 4-FMA (±3 mg tolerance), eliminating weighing errors and reducing operator exposure to fine particulate matter. Pellets are individually wrapped in aluminium foil or sealed in amber vials to protect from light and moisture, ensuring stability during storage and transport. For stock solution preparation, a single 150 mg pellet can be dissolved directly in 10 mL of methanol or DMSO to yield a 15 mg/mL stock solution (approximately 90 mM; molecular weight 167.23 g/mol for 4-FMA free base, or approximately 74 mM for hydrochloride salt at 203.69 g/mol), or in 20 mL to yield 7.5 mg/mL (approximately 45 mM), streamlining workflow and minimising handling time.

4-FMA pellets exhibit moderate susceptibility to photolytic degradation and oxidative breakdown, necessitating strict storage protocols to maintain analytical integrity over extended periods. Pellets should be stored at -20°C in amber glass vials with PTFE-lined caps or in original light-resistant packaging, protected from light and maintained under desiccated conditions (relative humidity <10%) or under inert atmosphere (nitrogen or argon) to prevent oxidative degradation. For short-term use (up to 30 days), storage at +4°C in a dedicated laboratory refrigerator is acceptable, provided the packaging remains sealed and protected from ambient light. Long-term archival storage (-80°C under inert atmosphere) is recommended for reference standards intended for multi-year use in proficiency testing or inter-laboratory comparisons.

Critical safe handling prerequisites mandate that all manipulations of 4-FMA pellets occur within a certified chemical fume hood operating at a face velocity of 0.5 m/s or greater. Personnel must wear nitrile gloves (tested to EN 374 standards), safety goggles with side shields, and a laboratory coat compliant with EN 14126. Although the pellet format minimises airborne particulate exposure compared to powder, a certified particulate respirator (EN 149 FFP2 or higher) is recommended when crushing or dissolving pellets to prevent inhalation exposure. For stock solution preparation, 4-FMA demonstrates solubility in dimethyl sulfoxide (DMSO) to 100 mM, in methanol to approximately 100 mM, in anhydrous ethanol to 100 mM, and in dilute aqueous acid (e.g., 0.1 M HCl) to 50 mM; solutions should be prepared fresh daily or stored at -20°C in amber vials for no more than 7 days to prevent oxidative degradation.

Technical Specifications and Molecular Attributes

Pure Lab Chems .eu: Your Premier EU Vendor for High-Purity Reagents

Pure Lab Chems .eu transcends the conventional supplier role to serve as an indispensable partner in European scientific rigour. Our ISO 9001-certified quality management system governs every stage of material procurement, from batch selection through final CoA issuance, ensuring that each 4-FMA pellet batch (150 mg) meets the exacting standards demanded by analytical chemists and laboratory managers across all 27 EU member states. Our dedicated logistics chain employs temperature-controlled, discreet packaging with real-time tracking, guaranteeing that reference standards arrive in pristine condition regardless of destination—from Berlin to Barcelona, from Dublin to Athens.

Beyond logistics, Pure Lab Chems .eu distinguishes itself through expert customer support staffed by chemists capable of discussing analytical specifications, method validation requirements, and CoA interpretation. Whether you require guidance on HPLC method parameters for 4-FMA quantification or need clarification on residual solvent limits for your specific application, our technical team provides responsive, scientifically grounded assistance. We do not merely sell chemicals; we enable critical research outcomes by supplying rigorously tested, fully documented materials that form the foundation of trustworthy, reproducible science.